Sign in
4

Changes in Ownership

Iambic Therapeutics, Inc. Filed Acc 0001855980-26-000007

CFO & Chief Corp Dev Ofcr acquired 28,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Secora Michael CFO & Chief Corp Dev Ofcr 2026-10-14 Grant or award +28,400 218,560 D
Derivatives
Secora Michael CFO & Chief Corp Dev Ofcr 2026-10-14 Grant or award · Employee Stock Option (right to buy) +170,300 170,300 D
Loading xslF345X06/form4-10162026_081020.xml…